Skip to content

Effects of inhaled salbutamol on specific fitness standards in professional soccers, a double-blind clinical trial

Effects of inhaled salbutamol on specific fitness standards in professional soccers, a double-blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201205098117N3
Enrollment
30
Registered
2012-06-19
Start date
2012-05-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fitness for soccer players.

Interventions

Intervention 1: In the first group: salbutamol spray, two puffs of 100 micrograms and control groups: placebo homogenous spray, two puffs of 100 micrograms should be administered. Intervention 2: Afte
Treatment - Drugs
Placebo
In the first group: salbutamol spray, two puffs of 100 micrograms and control groups: placebo homogenous spray, two puffs of 100 micrograms should be administered
After wash out period :The second phase of the first drug to people who were given placebo and those on placebo was administered in the first stage of the drug is given

Sponsors

Reserch deputy, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
17 Years to 33 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having a contract with a professional team and regular exercise. Exclusion criteria: history of asthma and EIA; having a history of restrictive lung disease volume; having a history of heart disease; respiratory viral infections in a month; history of atopy and skeletal abnormalities of the chest.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Dedicated fitness. Timepoint: Before the intervention, 20 minutes after intervention. Method of measurement: Used FIFA standard test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehdi Abarashi

Tehran University of Medical Sciences

abarashi@razi.tums.ac.ir

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026